Cell cycle disruption could lead to infinite proliferation, which might play a critical role in liver cancer and a promising therapeutic target (37, 38), suggesting that MRPL9 may function a critical role in the tumorigenesis of HCC. Here, MRPL9 is linked to hepatocellular carcinoma.